Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of...

Equinix, Inc. (Nasdaq: EQIX), the world's digital infrastructure company®, today announced that Simon Miller, Chief Accounting Officer, will present at Nareit REITweek Conference on Tuesday, June...

Mech-Mind Robotics, a leading provider of industrial 3D sensors and AI-powered software for intelligent robotics, impressed the visitors at the highly anticipated Automate Show 2023 in Detroit,...

12-month results from the SELUTION SFA trial have been presented at the Japan Endovascular Treatment (JET) Conference in Tokyo. The objective of this study was to assess the safety and efficacy of...

Inmagene Biopharmaceuticals ("Inmagene"), a global clinical-stage biotechnology company focused on developing novel therapeutics for immunology-related diseases, today announced that management...